C R Bard Inc (BCR)
20 Dec 2013
|Market Cap (Mil.):||$10,293.20|
|Shares Outstanding (Mil.):||77.89|
- Medical device company C. R. Bard Inc said it would buy Rochester Medical Inc, which makes products for urinary retention and incontinence, for about $262 million to boost its presence in the urology homecare market.
* Bard to pay $20/shr, a premium of 45 pct over Rockwell's last close
Sept 4 - Medical device company C. R. Bard Inc said it will buy urology products maker Rochester Medical Inc for about $262 million to boost its presence in the urology homecare market.
June 28 - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Friday:
WASHINGTON, June 28 - Medical device maker Boston Scientific Corp said on Friday it would buy the electrophysiology (EP) business of C.R. Bard Inc for $275 million in cash, expanding its roster of products that help treat patients with an abnormal heartbeat.
|Johnson & Johnson (JNJ.N)||$92.09||+0.11|
|Abbott Laboratories (ABT.N)||$37.84||-0.19|
|Covidien plc (COV.N)||$65.72||+0.13|
|Becton, Dickinson and Co. (BDX.N)||$108.88||+0.86|
|Boston Scientific Corporation (BSX.N)||$11.84||+0.22|
|St. Jude Medical, Inc. (STJ.N)||$61.89||+1.07|
|Teleflex Incorporated (TFX.N)||$93.96||+0.11|
|AngioDynamics, Inc. (ANGO.OQ)||$16.47||+0.44|
Earnings vs. Estimates
Analyst Research Reports
Trading Report for (BCR). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
Provider: Pechala's Reports
Provider: Thomson Reuters Stock Report
Validea Guru Analysis Report for BCR. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.
Provider: New Constructs, LLC